Results 11 to 20 of about 63 (58)

[Application of dynamic contrast enhanced status in multiparametric magnetic resonance imaging for prostatic cancer with PI-RADS 4 lesion]. [PDF]

open access: yesBeijing Da Xue Xue Bao Yi Xue Ban, 2023
Yuan CW   +6 more
europepmc   +1 more source

[Bipolar androgen therapy followed by immune checkpoint inhibitors in metastatic castration resistant prostate cancer: A report of 4 cases]. [PDF]

open access: yesBeijing Da Xue Xue Bao Yi Xue Ban, 2022
Liu SJ   +6 more
europepmc   +1 more source

Prediction of pelvic lymph node metastasis in prostate cancer using radiomics based on T2-weighted imaging. [PDF]

open access: yesZhong Nan Da Xue Xue Bao Yi Xue Ban, 2022
Liu X   +5 more
europepmc   +1 more source

[High expression of MYBL2 promotes progression and predicts a poor survival outcome of prostate cancer]. [PDF]

open access: yesNan Fang Yi Ke Da Xue Xue Bao, 2022
Yang M   +7 more
europepmc   +1 more source

[68Ga-PSMA-I&T PET/CT for assessment of tumor burden in primary lesions of treatmentnaïve prostate cancer]. [PDF]

open access: yesNan Fang Yi Ke Da Xue Xue Bao, 2022
Xie Y   +6 more
europepmc   +1 more source

[Relationship between prostate apex depth and early recovery of urinary continence after laparoscopic radical prostatectomy]. [PDF]

open access: yesBeijing Da Xue Xue Bao Yi Xue Ban, 2021
Zhang F   +7 more
europepmc   +1 more source

[Research status and prospect of artificial intelligence technology in the diagnosis of urinary system tumors]. [PDF]

open access: yesSheng Wu Yi Xue Gong Cheng Xue Za Zhi, 2021
Liu K   +9 more
europepmc   +1 more source

Progress in diagnosis of bone metastasis of prostate cancer. [PDF]

open access: yesZhong Nan Da Xue Xue Bao Yi Xue Ban, 2021
Liu J   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy